Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Bioorganic & Medicinal Chemistry Letters|January 20, 2007
Synthesis of 3-(1H-benzimidazol-2-yl)-5-isoquinolin-4-ylpyrazolo[1,2-b]pyridine, a potent cyclin dependent kinase 1 (CDK1) inhibitorShenlin Huang, Ronghui Lin, Yang Yu, et al.
The Prostate|December 1, 2020
AKR1C3 mediates pan-AR antagonist resistance in castration-resistant prostate cancerJennifer R Hertzog, Zhuming Zhang, Gilles Bignan, et al.
The Journal of Organic Chemistry|January 4, 2008
Scalable synthesis of the VEGF-R2 kinase inhibitor JNJ-17029259 using ultrasound-mediated addition of MeLi-CeCl3 to a nitrileMichael Reuman, Sandra Beish, Jeremy Davis, et al.
Structure (London, England : 1993)|September 13, 2016
From Nanodiscs to Isotropic Bicelles: A Procedure for Solution Nuclear Magnetic Resonance Studies of Detergent-Sensitive Integral Membrane ProteinsAisha Laguerre, Frank Löhr, Erik Henrich, et al.
Journal of Magnetic Resonance (San Diego, Calif. : 1997)|December 3, 2014
Time-shared experiments for efficient assignment of triple-selectively labeled proteinsFrank Löhr, Aisha Laguerre, Christoph Bock, et al.
The Journal of Biological Chemistry|December 15, 2004
The nociceptin pharmacophore site for opioid receptor binding derived from the NMR structure and bioactivity relationshipsMichael J Orsini, Irina Nesmelova, Helen C Young, et al.
Bioorganic & Medicinal Chemistry Letters|August 23, 2008
7-[1H-Indol-2-yl]-2,3-dihydro-isoindol-1-ones as dual Aurora-A/VEGF-R2 kinase inhibitors: design, synthesis, and biological activityTerry V Hughes, Stuart L Emanuel, Harold R O'Grady, et al.
Angiogenesis|June 23, 2009
A highly selective, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor has potent activity in vitro and in vivoKenneth R LaMontagne, Jeannene Butler, Virna B Borowski, et al.
Bioorganic & Medicinal Chemistry Letters|June 19, 2007
Design, synthesis, and evaluation of 3,4-disubstituted pyrazole analogues as anti-tumor CDK inhibitorsRonghui Lin, George Chiu, Yang Yu, et al.
Bioorganic & Medicinal Chemistry Letters|September 28, 2016
Tetrahydroindazole derivatives as potent and peripherally selective cannabinoid-1 (CB1) receptor inverse agonistsJay M Matthews, James J McNally, Peter J Connolly, et al.
Pageof 6